NASDAQ:BASI Bioanalytical Systems (BASI) Stock Price, News & Analysis → Gold Mania (From Stansberry Research) (Ad) Free BASI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.15▼$4.6350-Day Range$14.04▼$22.5052-Week Range$3.05▼$21.08Volume418,993 shsAverage Volume122,925 shsMarket Capitalization$47.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Get Bioanalytical Systems alerts: Email Address Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report About Bioanalytical Systems Stock (NASDAQ:BASI)Bioanalytical Systems, Inc., doing business as Inotiv, provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. BioVaxys has an agreement with Inotiv to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.Read More Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report BASI Stock News HeadlinesApril 29, 2024 | yahoo.comWhat a Basic Metabolic Panel (BMP) MeasuresApril 2, 2024 | markets.businessinsider.com10 Analysts Assess NIO: What You Need To KnowMay 4, 2024 | Weiss Ratings (Ad)FW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.March 27, 2024 | msn.comWhat Is Bioprocessing? Here Are the BasicsFebruary 12, 2024 | markets.businessinsider.comWhat 11 Analyst Ratings Have To Say About Analog DevicesJanuary 29, 2024 | markets.businessinsider.comDemystifying Airbnb: Insights From 13 Analyst ReviewsJanuary 26, 2024 | techrepublic.com7 Best B2B Database Providers for 2024November 20, 2023 | markets.businessinsider.comGCCL Wins Top 10 Bioanalytical Services Providers in APAC 2023May 4, 2024 | Weiss Ratings (Ad)FW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.November 9, 2023 | techrepublic.comWhat Are Data Analytics Tools? A Comprehensive OverviewMay 5, 2023 | marketwatch.comBioanalytical Testing Services Market by Product Type and Consumers-2030December 21, 2022 | marketwatch.comBioanalytical Testing Services Market : Research Report Analysis by Competitors, Sales, Revenue and Industry Size 2023 To 2029December 14, 2022 | finance.yahoo.comAlliance Pharma Opens State-of-the-Art Bioanalytical Laboratory in BrisbaneSeptember 25, 2022 | msn.comSprinkler Systems: Irrigation Design BasicsAugust 25, 2022 | uk.finance.yahoo.com"People are starting to forget – but the war in Ukraine is not over, we still need help"August 13, 2022 | ca.finance.yahoo.comInsights on the Bioanalytical Testing Services Global Market to 2027 - Emerging Countries in the Asia Pacific Region Present OpportunitiesAugust 10, 2022 | forbes.comGetting Deeper With Advanced Analytics: Become A More Data-Driven Company With The Help Of AIJuly 22, 2022 | forbes.comFour Types Of Business AnalyticsJuly 10, 2022 | finance.yahoo.comValue of Bioanalytical Testing Services Market Estimated at US$ 8.95 Bn by 2031, TMR ReportJune 24, 2022 | finance.yahoo.comBioanalytical Testing Services Market Forecast to 2027: Industry Projected to Reach $6.0 Billion from $2.9 billion in 2022, at a CAGR of 15.6%June 17, 2022 | uk.finance.yahoo.comNetflix Canada Commissioners: “We Won’t Come Here And Upend The Market” – BanffJune 15, 2022 | benzinga.comBioanalytical Testing Services Market by Type, Application, End User and Region - Global Forecast to 2027June 6, 2022 | finance.yahoo.comBioanalytical Testing Services Market worth $6.0 billion by 2027 - Exclusive Report by MarketsandMarkets™May 30, 2022 | forbes.comOperationalizing Advanced Analytics And AI At Scotiabank.May 23, 2022 | seekingalpha.comWaters Corporation (WAT) CEO Dr. Udit Batra Hosts 2022 Investor Day Conference (Transcript)May 3, 2022 | insidermonkey.comIs Inotiv (NOTV) a Smart Long-Term Buy?February 26, 2022 | yahoo.comShoppers Love This Stylish Leather Backpack for Travel — and It's on SaleSee More Headlines Receive BASI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioanalytical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/08/2021Today5/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial Physical Research Sub-IndustryN/A Current SymbolNASDAQ:BASI CUSIPN/A CIK720154 Webwww.basinc.com Phone765-463-4527FaxN/AEmployees397Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,680,000.00 Net Margins-7.75% Pretax MarginN/A Return on Equity-42.74% Return on Assets-6.38% Debt Debt-to-Equity Ratio2.49 Current Ratio0.48 Quick Ratio0.46 Sales & Book Value Annual Sales$60.47 million Price / Sales0.79 Cash Flow$0.01 per share Price / Cash Flow558.40 Book Value$0.69 per share Price / Book6.19Miscellaneous Outstanding Shares11,131,000Free FloatN/AMarket Cap$47.53 million OptionableNot Optionable Beta1.92 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Robert W. Leasure Jr. (Age 61)Pres, CEO & Director Comp: $529.23kDr. John E. Sagartz D.V.M. (Age 56)DiplomateACVP, DVM, Ph.D., Chief Strategy Officer & Director Comp: $289.82kMr. Joseph Earl Flynn (Age 56)Chief Commercial Officer Comp: $310kDr. Peter T. Kissinger (Age 76)Founder, Chairman Emeritus & Scientific Advisor Ms. Beth A. Taylor CPA (Age 56)CFO, VP of Fin. & Sec. Mr. John Gregory BeattieChief Operating OfficerMr. William D. Pitchford (Age 66)Chief HR Officer Mr. Philip A. Downing (Age 51)Sr. VP of Nonclinical Services Dr. Michael A. Baim Ph.D. (Age 64)Sr. VP of Analytical Operations Dr. J. Scott DanielsSr. VP of DMPKMore ExecutivesKey CompetitorsbioAffinity TechnologiesNASDAQ:BIAFLuna InnovationsNASDAQ:LUNAAIkido PharmaNASDAQ:AIKIInotivNASDAQ:NOTVDyadic InternationalNASDAQ:DYAIView All Competitors BASI Stock Analysis - Frequently Asked Questions How were Bioanalytical Systems' earnings last quarter? Bioanalytical Systems, Inc. (NASDAQ:BASI) issued its quarterly earnings data on Monday, February, 8th. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.19) by $0.16. The firm earned $17.89 million during the quarter. Bioanalytical Systems had a negative trailing twelve-month return on equity of 42.74% and a negative net margin of 7.75%. Read the conference call transcript. What is Jacqueline Lemke's approval rating as Bioanalytical Systems' CEO? 6 employees have rated Bioanalytical Systems Chief Executive Officer Jacqueline Lemke on Glassdoor.com. Jacqueline Lemke has an approval rating of 20% among the company's employees. This puts Jacqueline Lemke in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Bioanalytical Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bioanalytical Systems investors own include Riot Platforms (RIOT), Boeing (BA), NVIDIA (NVDA), Overstock.com (OSTK), Enphase Energy (ENPH), Pure Storage (PSTG), Mastercard (MA), Main Street Capital (MAIN), QUALCOMM (QCOM) and Toll Brothers (TOL). This page (NASDAQ:BASI) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioanalytical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.